Q&A With Arnold & Porter's Dan Kracov

Law360, New York (June 18, 2012, 6:03 PM EDT) -- Daniel A. Kracov is a partner in Arnold & Porter LLP’s Washington, D.C., office, where he chairs the firm's U.S. Food and Drug Administration and healthcare practice. For 24 years, he has helped large manufacturing companies, trade associations and early-stage ventures negotiate challenges relating to the development, approval and promotion of drugs, biologics, medical devices and diagnostics. Kracov also regularly handles high investigations and enforcement proceedings, the development of global compliance programs, and due diligence in financings, mergers and acquisitions.

Q: What is the most challenging...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.